Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 458075, 13 pages
http://dx.doi.org/10.1155/2013/458075
Research Article

A Type II Arabinogalactan from Anoectochilus formosanus for G-CSF Production in Macrophages and Leukopenia Improvement in CT26-Bearing Mice Treated with 5-Fluorouracil

1Institute of Food Science and Technology, National Taiwan University, Taipei, Taiwan
2School of Medicine, Graduate Institute of Basic Medical Science and Tsuzuki Institute for Traditional Medicine, China Medical University, No. 91 Hsueh Shih Road, Taichung 40402, Taiwan

Received 19 June 2013; Revised 20 August 2013; Accepted 27 August 2013

Academic Editor: Tzeng-Ji Chen

Copyright © 2013 Li-Chan Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. B. Wu, W. L. Lin, C. C. Hsieh, H. Y. Ho, H. S. Tsay, and W. C. Lin, “The hepatoprotective activity of kinsenoside from Anoectochilus formosanus,” Phytotherapy Research, vol. 21, no. 1, pp. 58–61, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. L. F. Shyur, C. H. Chen, C. P. Lo et al., “Induction of apoptosis in MCF-7 human breast cancer cells by phytochemicals from Anoectochilus formosanus,” Journal of Biomedical Science, vol. 11, no. 6, pp. 928–939, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. C. C. Tseng, H. F. Shang, L. F. Wang et al., “Antitumor and immunostimulating effects of Anoectochilus formosanus Hayata,” Phytomedicine, vol. 13, no. 5, pp. 366–370, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. C. C. Hsieh, H. B. Hsiao, and W.-C. Lin, “A standardized aqueous extract of Anoectochilus formosanus modulated airway hyperresponsiveness in an OVA-inhaled murine model,” Phytomedicine, vol. 17, no. 8-9, pp. 557–562, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. C. C. Shih, Y. W. Wu, and W. C. Lin, “Antihyperglycaemic and anti-oxidant properties of Anoectochilus formosanus in diabetic rats,” Clinical and Experimental Pharmacology and Physiology, vol. 29, no. 8, pp. 684–688, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. L. C. Yang, W. C. Lin, and T. J. Lu, “Characterization and prebiotic activity of aqueous extract and indigestible polysaccharide from Anoectochilus formosanus,” Journal of Agricultural and Food Chemistry, vol. 60, no. 35, pp. 8590–8599, 2012. View at Publisher · View at Google Scholar
  7. L. C. Yang, J. B. Wu, T. J. Lu, and W. C. Lin, “The prebiotic effect of Anoectochilus formosanus and its consequences on bone health,” British Journal of Nutrition, vol. 109, no. 10, pp. 1779–1788, 2013. View at Publisher · View at Google Scholar
  8. C. C. Shih, Y. W. Wu, and W. C. Lin, “Ameliorative effects of Anoectochilus formosanus extract on osteopenia in ovariectomized rats,” Journal of Ethnopharmacology, vol. 77, no. 2-3, pp. 233–238, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. I. A. Schepetkin and M. T. Quinn, “Botanical polysaccharides: macrophage immunomodulation and therapeutic potential,” International Immunopharmacology, vol. 6, no. 3, pp. 317–333, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Beekman and I. P. Touw, “G-CSF and its receptor in myeloid malignancy,” Blood, vol. 115, no. 25, pp. 5131–5136, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. E. M. Boneberg and T. Hartung, “Molecular aspects of anti-inflammatory action of G-CSF,” Inflammation Research, vol. 51, no. 3, pp. 119–128, 2002. View at Google Scholar · View at Scopus
  12. I. Gorgen, T. Hartung, M. Leist et al., “Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-α,” Journal of Immunology, vol. 149, no. 3, pp. 918–924, 1992. View at Google Scholar · View at Scopus
  13. S. Nishiki, F. Hato, N. Kamata et al., “Selective activation of STAT3 in human monocytes stimulated by G-CSF: implication in inhibition of LPS-induced TNF-α production,” American Journal of Physiology, vol. 286, no. 6, pp. C1302–C1311, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. H. F. Liao, Y. J. Chen, and Y. C. Yang, “A novel polysaccharide of black soybean promotes myelopoiesis and reconstitutes bone marrow after 5-flurouracil- and irradiation-induced myelosuppression,” Life Sciences, vol. 77, no. 4, pp. 400–413, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. Z. Jiang, T. Okimura, K. Yamaguchi, and T. Oda, “The potent activity of sulfated polysaccharide, ascophyllan, isolated from Ascophyllum nodosum to induce nitric oxide and cytokine production from mouse macrophage RAW264.7 cells: comparison between ascophyllan and fucoidan,” Nitric Oxide, vol. 25, no. 4, pp. 407–415, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Ito, Y. Masuda, Y. Yamasaki, Y. Yokota, and H. Nanba, “Maitake beta-glucan enhances granulopoiesis and mobilization of granulocytes by increasing G-CSF production and modulating CXCR4/SDF-1 expression,” International Immunopharmacology, vol. 9, no. 10, pp. 1189–1196, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Masuda, M. Inoue, A. Miyata, S. Mizuno, and H. Nanba, “Maitake β-glucan enhances therapeutic effect and reduces myelosupression and nephrotoxicity of cisplatin in mice,” International Immunopharmacology, vol. 9, no. 5, pp. 620–626, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Lin, E. de Stanchina, X. K. Zhou et al., “Maitake beta-glucan promotes recovery of leukocytes and myeloid cell function in peripheral blood from paclitaxel hematotoxicity,” Cancer Immunology, Immunotherapy, vol. 59, no. 6, pp. 885–897, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. J. J. Volman, J. D. Ramakers, and J. Plat, “Dietary modulation of immune function by β-glucans,” Physiology and Behavior, vol. 94, no. 2, pp. 276–284, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Crawford, D. C. Dale, and G. H. Lyman, “Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management,” Cancer, vol. 100, no. 2, pp. 228–237, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Ozer, “Chemotherapy-induced neutropenia: new approaches to an old problem,” Seminars in Oncology, vol. 30, no. 4, pp. 1–2, 2003. View at Google Scholar · View at Scopus
  22. O. A. Clark, G. H. Lyman, A. A. Castro, L. G. O. Clark, and B. Djulbegovic, “Colony-stimulating factors for chemotherapy-induced febrile neutropenia: a meta-analysis of randomized controlled trials,” Journal of Clinical Oncology, vol. 23, no. 18, pp. 4198–4214, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Natori, L. W. Law, and E. Appella, “Biological and biochemical properties of Nonidet P40-solubilized and partially purified tumor-specific antigens of the transplantation type from plasma membranes of a methylcholanthrene-induced sarcoma,” Cancer Research, vol. 37, no. 9, pp. 3406–3413, 1977. View at Google Scholar · View at Scopus
  24. M. M. Tomayko and C. P. Reynolds, “Determination of subcutaneous tumor size in athymic (nude) mice,” Cancer Chemotherapy and Pharmacology, vol. 24, no. 3, pp. 148–154, 1989. View at Google Scholar · View at Scopus
  25. A. E. Clarke, R. L. Anderson, and B. A. Stone, “Form and function of arabinogalactans and arabinogalactan-proteins,” Phytochemistry, vol. 18, no. 4, pp. 521–540, 1979. View at Google Scholar · View at Scopus
  26. S. W. Hinz, R. Verhoef, H. A. Schols, J. Vincken, and A. G. J. Voragen, “Type I arabinogalactan contains β-D-Galp-(1→3)-β-D-Galp structural elements,” Carbohydrate Research, vol. 340, no. 13, pp. 2135–2143, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. B. Classen, S. Thude, W. Blaschek, M. Wack, and C. Bodinet, “Immunomodulatory effects of arabinogalactan-proteins from Baptisia and Echinacea,” Phytomedicine, vol. 13, no. 9-10, pp. 688–694, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. G. S. Kelly, “Larch arabinogalactan: clinical relevance of a novel immune-enhancing polysaccharide,” Alternative Medicine Review, vol. 4, no. 2, pp. 96–103, 1999. View at Google Scholar · View at Scopus
  29. G. D. Demetri and J. D. Griffin, “Granulocyte colony-stimulating factor and its receptor,” Blood, vol. 78, no. 11, pp. 2791–2808, 1991. View at Google Scholar · View at Scopus
  30. A. D. Panopoulos and S. S. Watowich, “Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and “emergency” hematopoiesis,” Cytokine, vol. 42, no. 3, pp. 277–288, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Pradervand, M. R. Maurya, and S. Subramaniam, “Identificaton of signaling components required for the prediction of cytokine release in RAW 264.7 macrophages,” Genome Biology, vol. 7, no. 2, p. R11, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Herlaar and Z. Brown, “p38 MAPK signalling cascades in inflammatory disease,” Molecular Medicine Today, vol. 5, no. 10, pp. 439–447, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. D. Shaul and R. Seger, “The MEK/ERK cascade: from signaling specificity to diverse functions,” Biochimica et Biophysica Acta, vol. 1773, no. 8, pp. 1213–1226, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. S. M. Dunn, L. S. Coles, R. K. Lang, S. Gerondakis, M. A. Vadas, and M. F. Shannon, “Requirement for nuclear factor (NF)-κB p65 and NF-interleukin-6 binding elements in the tumor necrosis factor response region of the granulocyte colony-stimulating factor promoter,” Blood, vol. 83, no. 9, pp. 2469–2479, 1994. View at Google Scholar · View at Scopus
  35. L. Hareng, T. Meergans, S. von Aulock, H. Volk, and T. Hartung, “Cyclic AMP increases endogenous granulocyte colony-stimulating factor formation in monocytes and THP-1 macrophages despite attenuated TNF-α formation,” European Journal of Immunology, vol. 33, no. 8, pp. 2287–2296, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Worm, J. Stenvang, A. Petri et al., “Silencing of microRNA-155 in mice during acute inflammatory response leads to derepression of c/ebp Beta and down-regulation of G-CSF,” Nucleic Acids Research, vol. 37, no. 17, Article ID gkp577, pp. 5784–5792, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. H. Cho, C. H. Lee, and S. G. Kim, “Potentiation of lipopolysaccharide-inducible cyclooxygenase 2 expression by C2-ceramide via c-Jun N-terminal kinase-mediated activation of CCAAT/enhancer binding protein β in macrophages,” Molecular Pharmacology, vol. 63, no. 3, pp. 512–523, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. R. A. Putland, T. A. Sassinis, J. S. Harvey et al., “RNA destabilization by the granulocyte colony-stimulating factor stem-loop destabilizing element involves a single stem-loop that promotes deadenylation,” Molecular and Cellular Biology, vol. 22, no. 6, pp. 1664–1673, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. M. A. Frevel, T. Bakheet, A. M. Silva, J. G. Hissong, K. S. A. Khabar, and B. R. G. Williams, “p38 mitogen-activated protein kinase-dependent and -independent signaling of mRNA stability of AU-rich element-containing transcripts,” Molecular and Cellular Biology, vol. 23, no. 2, pp. 425–436, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Gordon, “Pattern recognition receptors: doubling up for the innate immune response,” Cell, vol. 111, no. 7, pp. 927–930, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Yadav and J. S. Schorey, “The β-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria,” Blood, vol. 108, no. 9, pp. 3168–3175, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Dillon, S. Agrawal, K. Banerjee et al., “Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance,” Journal of Clinical Investigation, vol. 116, no. 4, pp. 916–928, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Lu, Y. Yang, E. Gad et al., “Polysaccharide krestin is a novel TLR2 agonist that mediates inhibition of tumor growth via stimulation of CD8 T cells and NK cells,” Clinical Cancer Research, vol. 17, no. 1, pp. 67–76, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. E. Shochat and V. Rom-Kedar, “Novel strategies for granulocyte colony-stimulating factor treatment of severe prolonged neutropenia suggested by mathematical modeling,” Clinical Cancer Research, vol. 14, no. 20, pp. 6354–6363, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Pelusi, “Capecitabine versus 5-FU in metastatic colorectal cancer: considerations for treatment decision-making,” Community Oncology, vol. 3, no. 1, pp. 19–27, 2006. View at Google Scholar · View at Scopus